rs186382346

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_198152.5(UTS2B):​c.-664-583C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00371 in 203,228 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0035 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0042 ( 0 hom. )

Consequence

UTS2B
NM_198152.5 intron

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 1.62

Publications

0 publications found
Variant links:
Genes affected
CCDC50 (HGNC:18111): (coiled-coil domain containing 50) This gene encodes a soluble, cytoplasmic, tyrosine-phosphorylated protein with multiple ubiquitin-interacting domains. Mutations in this gene cause nonsyndromic, postlingual, progressive sensorineural DFNA44 hearing loss. In mouse, the protein is expressed in the inner ear during development and postnatal maturation and associates with microtubule-based structures. This protein may also function as a negative regulator of NF-kB signaling and as an effector of epidermal growth factor (EGF)-mediated cell signaling. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]
UTS2B (HGNC:30894): (urotensin 2B) Predicted to enable G protein-coupled receptor binding activity. Predicted to be involved in regulation of blood pressure. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 3-191329292-G-A is Benign according to our data. Variant chr3-191329292-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 1196503.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
UTS2BNM_198152.5 linkc.-664-583C>T intron_variant Intron 1 of 8 ENST00000340524.10 NP_937795.2 Q765I0
CCDC50NM_178335.3 linkc.-383G>A upstream_gene_variant ENST00000392455.9 NP_848018.1 Q8IVM0-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
UTS2BENST00000340524.10 linkc.-664-583C>T intron_variant Intron 1 of 8 2 NM_198152.5 ENSP00000340526.5 Q765I0
CCDC50ENST00000392455.9 linkc.-383G>A upstream_gene_variant 1 NM_178335.3 ENSP00000376249.4 Q8IVM0-2

Frequencies

GnomAD3 genomes
AF:
0.00355
AC:
540
AN:
152236
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000796
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00425
Gnomad ASJ
AF:
0.000577
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00536
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00548
Gnomad OTH
AF:
0.00382
GnomAD4 exome
AF:
0.00421
AC:
214
AN:
50874
Hom.:
0
Cov.:
0
AF XY:
0.00429
AC XY:
110
AN XY:
25642
show subpopulations
African (AFR)
AF:
0.000700
AC:
1
AN:
1428
American (AMR)
AF:
0.00647
AC:
6
AN:
928
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1802
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2400
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2320
European-Finnish (FIN)
AF:
0.00415
AC:
13
AN:
3134
Middle Eastern (MID)
AF:
0.00329
AC:
1
AN:
304
European-Non Finnish (NFE)
AF:
0.00524
AC:
184
AN:
35092
Other (OTH)
AF:
0.00260
AC:
9
AN:
3466
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
11
23
34
46
57
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00354
AC:
540
AN:
152354
Hom.:
2
Cov.:
33
AF XY:
0.00361
AC XY:
269
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.000793
AC:
33
AN:
41600
American (AMR)
AF:
0.00425
AC:
65
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.000577
AC:
2
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4832
European-Finnish (FIN)
AF:
0.00536
AC:
57
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00548
AC:
373
AN:
68018
Other (OTH)
AF:
0.00378
AC:
8
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
26
52
78
104
130
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00805
Hom.:
2
Bravo
AF:
0.00327

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Sep 02, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
11
DANN
Benign
0.93
PhyloP100
1.6
PromoterAI
0.031
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs186382346; hg19: chr3-191047081; API